InflaRx (IFRX) Loses -15.29% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Portfolio Pulse from
InflaRx (IFRX) has experienced a substantial 15.29% decline over the past 4 weeks, but technical indicators suggest the stock might be oversold. Wall Street analysts are showing optimism by raising earnings estimates, which could signal a potential trend reversal for the biotech stock.
March 26, 2025 | 2:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
InflaRx stock has been under selling pressure, but current technical indicators point to an oversold condition that might precede a trend reversal.
The stock's significant decline combined with oversold technical indicators and positive analyst earnings estimates suggest a potential short-term price recovery.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 100